Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Self-guided online compassion therapy may improve quality of life in chronic illness

A fully self-guided, internet-delivered attachment-based compassion therapy improved overall quality of life and reduced preoccupied attachment compared with a waiting-list control in adults with chronic medical conditions. The findings are preliminary, with high attrition, no active control, and most secondary psychological outcomes showing no significant between-group differences.

16 Aug 2026

Three minutes of sprinting dramatically reshape molecular contents of the bloodstream

Three minutes of sprinting can do something that 90 minutes of moderate exercise apparently cannot: dramatically reshape the molecular contents of the bloodstream.

14 Aug 2026

Finnish study links habitual coffee consumption to healthier body metabolism

Coffee is one of the world's most widely consumed beverages, and previous research has linked its consumption to a lower risk of conditions such as type 2 diabetes and cardiovascular disease.

13 Aug 2026

$Bone loss alone fails to explain diabetes-related fracture risk$

Bone loss alone fails to explain diabetes-related fracture risk

A new study published in Diabetes Care finds that bone loss alone does not explain the increased fracture risk observed in some older adults with type 2 diabetes.

11 Aug 2026

Semaglutide slows blood protein signature linked to future dementia risk

A post hoc analysis of 2,970 older SELECT participants found that semaglutide slowed worsening of a 25-protein blood signature that predicts future dementia risk. Over 104 weeks, semaglutide produced larger effects on modeled 5-year than 20-year dementia risk, but whether these biomarker changes translate into less cognitive decline or dementia remains unknown.

10 Aug 2026

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

In a US cohort of 52,971 adults with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide initiation was associated with a lower one-year risk of major adverse cardiovascular events than sitagliptin. The benefit was driven mainly by lower myocardial infarction and all-cause mortality hazards, although the authors cautioned that mortality findings may be influenced by residual confounding.

10 Aug 2026

Thinning cancer cells' sugar coating could expose tumors to immune attack

Like spies evading detection through being masters of disguise, many cancer cells are adorned with a copious coat of sugar-derived molecules that throws the proverbial hounds of our immune systems off the scent.

7 Aug 2026

Genetic analysis of 1 million people points to FNIP1 as a promising metabolic target

Mega-scale exome sequencing of 1,032,116 people identified 59 independent genes linked to the TG:HDL ratio, including 44 rare-coding associations not detected in the previous largest analysis. Ultra-rare FNIP1 loss-of-function variants were associated with favorable fat distribution, lower liver fat and glycemia, and around 60% lower odds of a composite cardiometabolic disease outcome.

7 Aug 2026

Swiss flagship project harnesses AI and sensors for diabetes prevention

Type 2 diabetes generates high healthcare costs in Switzerland and causes significant suffering for those affected.

6 Aug 2026

New research highlights hidden metabolic risks in non-obese HIV patients

A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.

6 Aug 2026

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.

5 Aug 2026

Type 2 diabetes linked to more severe menopause symptoms

The type of menopause symptoms, as well as their severity, can differ greatly among women. A number of earlier studies have suggested various reasons for those differences.

5 Aug 2026

$GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes$

GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes

New research by UCLA Health found GLP-1 medications may reduce the risk of serious fractures for adults with type 2 diabetes.

4 Aug 2026

Exercise helps protect Hispanic adults from late life cognitive decline

Previous studies have examined the associations between adherence to LS7 and cognitive outcomes, with findings suggesting that higher LS7 scores are associated with better cognitive performance, reduced dementia risk and improved brain health.

4 Aug 2026

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Obesity has been linked to skeletal muscle loss and deterioration. While M2 macrophages may play a role in regulating muscle function, the underlying mechanisms remain poorly understood.

4 Aug 2026

Continuous glucose monitors show no proven benefits for healthy people

Continuous glucose monitors are becoming increasingly popular, including among people without diabetes.

4 Aug 2026

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Researchers studying 188 adults aged 85 years or older with type 2 diabetes found the lowest serum 25(OH)D concentrations among those with both depressive symptoms and mild cognitive impairment. Lower levels remained associated with having both conditions after adjustment for selected factors, but the cross-sectional study cannot establish causation or a benefit from supplementation.

3 Aug 2026

Gestational diabetes cases surge across England, raising health concerns

One in eight mothers in England is now diagnosed with gestational diabetes, with diagnoses rising by 60 per cent in just five years, according to a major study.

3 Aug 2026

Ten-million-person study links semaglutide to lower COVID-19 mortality

Researchers analyzing claims from more than 10.1 million commercial insurance and Medicare Advantage enrollees found that semaglutide use was associated with a 49% lower adjusted hazard of COVID-19-related death. The observational findings corroborate earlier SELECT trial results but do not establish causation, making further prospective research essential.

30 Jul 2026

Researchers train AI to detect diabetes and assign four diagnostic labels

Researchers developed a two-stage machine learning framework that detected diabetes and classified records as prediabetes, type 1, type 2, or type 3c diabetes using two public datasets. XGBoost showed strong internal performance, but inconsistent model rankings, non-standard variables, and the absence of external clinical validation limit immediate use.

29 Jul 2026

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Self-guided online compassion therapy may improve quality of life in chronic illness

Three minutes of sprinting dramatically reshape molecular contents of the bloodstream

Finnish study links habitual coffee consumption to healthier body metabolism

Bone loss alone fails to explain diabetes-related fracture risk

Semaglutide slows blood protein signature linked to future dementia risk

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

Thinning cancer cells' sugar coating could expose tumors to immune attack

Genetic analysis of 1 million people points to FNIP1 as a promising metabolic target

Swiss flagship project harnesses AI and sensors for diabetes prevention

New research highlights hidden metabolic risks in non-obese HIV patients

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Type 2 diabetes linked to more severe menopause symptoms

GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes

Exercise helps protect Hispanic adults from late life cognitive decline

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Continuous glucose monitors show no proven benefits for healthy people

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Gestational diabetes cases surge across England, raising health concerns

Ten-million-person study links semaglutide to lower COVID-19 mortality

Researchers train AI to detect diabetes and assign four diagnostic labels

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Newsletters you may be interested in